Chetana Lim1, Claire Goumard1,2, Chady Salloum3, Antonella Tudisco4, Niccolo Napoli4, Ugo Boggi4, Daniel Azoulay3,5, Olivier Scatton6,7,8. 1. Department of Hepato-Biliary and Pancreatic Surgery and Liver Transplantation, AP-HP Pitié-Salpêtrière Hospital, Paris, France. 2. Sorbonne Université, Paris, France. 3. Department of Hepato-Biliary and Pancreatic Surgery and Liver Transplantation, AP-HP Paul Brousse Hospital, Villejuif, France. 4. Division of General and Transplant Surgery, University of Pisa, Pisa, Italy. 5. Department of General Surgery and Transplantation, Hepatobiliary and Pancreatic Surgery, Tel Hashomer Hospital, Tel Aviv, Israel. 6. Department of Hepato-Biliary and Pancreatic Surgery and Liver Transplantation, AP-HP Pitié-Salpêtrière Hospital, Paris, France. olivier.scatton@aphp.fr. 7. Sorbonne Université, Paris, France. olivier.scatton@aphp.fr. 8. Centre de Recherche de Saint-Antoine (CRSA), INSERM, UMRS-938, Paris, France. olivier.scatton@aphp.fr.
Abstract
BACKGROUND: The recent development of 3D vision in laparoscopic and robotic surgical systems raises the question of whether these two procedures are equivalent. The aim of this study was to evaluate the surgical and long-term oncological outcomes of 3D laparoscopic (3D-LLR) and robotic liver resection (RLR) for hepatocellular carcinoma (HCC). METHODS: The data for operative time, morbidity, margins, and survival were reviewed for 3D-LLR and compared with RLR. RESULTS: From 2011 to 2017, 93 patients with HCC, including 58 (62%) with cirrhosis, underwent 3D-LLR [49 (53%)] or RLR [44 (47%)]. No difference was observed in operative time (269 vs. 252 min; p = 0.52), overall (27% vs. RLR: 16%; p = 0.49) and severe morbidity (4% vs. 2%; p = 0.77) or in the surgical margin width (9 vs. 11 mm; p = 0.30) between the 3D-LLR and RLR groups. The 3-year overall and recurrence-free survival rates after 3D-LLR and RLR were 82% and 24% and 91% (p = 0.16) and 48% (p = 0.18), respectively. CONCLUSIONS: The 3D-LLR and RLR systems provide comparable surgical margins with similar short- and long-term oncological outcomes.
BACKGROUND: The recent development of 3D vision in laparoscopic and robotic surgical systems raises the question of whether these two procedures are equivalent. The aim of this study was to evaluate the surgical and long-term oncological outcomes of 3D laparoscopic (3D-LLR) and robotic liver resection (RLR) for hepatocellular carcinoma (HCC). METHODS: The data for operative time, morbidity, margins, and survival were reviewed for 3D-LLR and compared with RLR. RESULTS: From 2011 to 2017, 93 patients with HCC, including 58 (62%) with cirrhosis, underwent 3D-LLR [49 (53%)] or RLR [44 (47%)]. No difference was observed in operative time (269 vs. 252 min; p = 0.52), overall (27% vs. RLR: 16%; p = 0.49) and severe morbidity (4% vs. 2%; p = 0.77) or in the surgical margin width (9 vs. 11 mm; p = 0.30) between the 3D-LLR and RLR groups. The 3-year overall and recurrence-free survival rates after 3D-LLR and RLR were 82% and 24% and 91% (p = 0.16) and 48% (p = 0.18), respectively. CONCLUSIONS: The 3D-LLR and RLR systems provide comparable surgical margins with similar short- and long-term oncological outcomes.
Entities:
Keywords:
3D vision; Hepatectomy; Hepatocellular carcinoma; Laparoscopic; Robotic
Authors: Go Wakabayashi; Daniel Cherqui; David A Geller; Joseph F Buell; Hironori Kaneko; Ho Seong Han; Horacio Asbun; Nicholas OʼRourke; Minoru Tanabe; Alan J Koffron; Allan Tsung; Olivier Soubrane; Marcel Autran Machado; Brice Gayet; Roberto I Troisi; Patrick Pessaux; Ronald M Van Dam; Olivier Scatton; Mohammad Abu Hilal; Giulio Belli; Choon Hyuck David Kwon; Bjørn Edwin; Gi Hong Choi; Luca Antonio Aldrighetti; Xiujun Cai; Sean Cleary; Kuo-Hsin Chen; Michael R Schön; Atsushi Sugioka; Chung-Ngai Tang; Paulo Herman; Juan Pekolj; Xiao-Ping Chen; Ibrahim Dagher; William Jarnagin; Masakazu Yamamoto; Russell Strong; Palepu Jagannath; Chung-Mau Lo; Pierre-Alain Clavien; Norihiro Kokudo; Jeffrey Barkun; Steven M Strasberg Journal: Ann Surg Date: 2015-04 Impact factor: 12.969
Authors: Anne-Sophie Mehdorn; Florian Richter; Katharina Hess; Jan Henrik Beckmann; Jan-Hendrik Egberts; Michael Linecker; Thomas Becker; Felix Braun Journal: J Clin Med Date: 2022-06-19 Impact factor: 4.964
Authors: Linh M Duong; Hui Cai; Martha J Shrubsole; Christina E Bailey; Kamran Idrees; Xiao-Ou Shu Journal: Cancer Date: 2021-10-21 Impact factor: 6.921